...Swerdlin, their target is “anyone who wants to be healthy”, but drilling down, it is the worried well, those wanting to centralize their ongoing testing, and those managing chronic conditions. Having gone through (and will be going through) a battery of thyroid and related tests, those of us who don’t have a physician brother to write up testing (and now an endocrinologist) could find this very attractive indeed, especially those with HSA/FSA accounts. For Medicare beneficiaries, it’s strictly out of pocket but if you have a lot of testing to do, perhaps worth it. The next part of this, of... Continue Reading
Search Results for chronic traumatic encephalopathy
News roundup: Withings Medical Group service launches, MPs urge cancellation of NHS/Palantir FDP contract, IKS closes TruBridge buy for $557M, ATA comments on prelim CMS PFS for telehealth, Philips’ AI-powered…toothbrush
Withings USA expands monitoring into clinical care services. Withings’ reach from devices into clinical care is definitely something unusual, as it’s rare that a device developer gets into the messy care space, much less with a ten-year commitment. Here Withings, with the Withings Medical Group, is entering care for Original Medicare beneficiaries via CMS’s new ACCESS Model (Advancing Chronic Care with Effective, Scalable Solutions). ACCESS is a ten-year CMS Innovation Center model that pays providers on chronic disease management outcomes. It launched on 5 July. Withings Medical Group will concentrate on cardiovascular, kidney, and metabolic health (CKM), beginning with hypertension,... Continue Reading
News roundup: Validic bought by ChartSpan; raises for Cadence, Prosper AI, Telepatia; Epic MyChart portal messages doubled in 5 years–study
The doldrums of M&A and fundings lightened a bit this week. Personal health data consolidator Validic acquired by ChartSpan. The care management services company will broaden its portfolio through integrating Validic’s IoT platform into its remote care management and health programs. These include chronic care management, advanced primary care management, remote patient monitoring, and custom programs for health systems, payers, and wellness programs. Acquisition cost was not disclosed. BIP Capital led the financing for ChartSpan, as they did with their $15 million Series A in 2019. Validic’s last raise was $12 million in 2022 led by Kaiser Permanente Ventures. Validic,... Continue Reading
News roundup: VSee refocuses business, transitions CEO; legacy PERS connectivity problems; South Korea’s AI ‘Talking Buddy’, expands telemedicine to foreign patients; Novellia’s $18M Series A
...consultations and follow-up care at clinic or hospital-level medical institutions, continuous observations, counseling, education, diagnosis, and prescriptions. Healthcare IT News Novellia garners $18 million Series A. The funding round for the New York-based company was led by Spark Capital with participation from Khosla Ventures, Acrew Capital, Bling Capital, and TMV, bringing Novellia’s total funding to $28 million. Their platform is targeted to patients with serious or chronic conditions, helping them to pull all their data from various health providers, add information, digitize paper records, and overall control their health history. Novellia most recently introduced a mobile app platform. The fresh... Continue Reading
Chutes & Ladders: Ad trackers still on healthcare websites after lawsuits, FTC; the US Navy adds WHOOPs it up and expands Talkspace; HealthVerity to buy Symphony Health; Nervonik’s $52.5M Series B
...this month. Release, Mobihealthnews Medical device company Nervonik announced an oversubscribed $52.5 million Series B funding round. Their peripheral nerve stimulation (PNS) neuromodulation technology is used in high-motion areas of the body for chronic pain treatment. The financing was led by Amzak Health, with participation from Elevage Medical Technologies, U.S. Venture Partners (USVP), Lumira Ventures, Foothill Ventures, and Shangbay Capital, bringing their total funding to over $65 million. Their PNS integrates stimulation with advanced sensing to deliver more precise and personalized therapy. Nervonik completed a first human clinical trial of nerve stimulation for chronic pain in March 2025. Release, Mobihealthnews... Continue Reading
‘AI doctor’ Doctronic raises $40M Series B, but faces controversy on autonomous Rx renewals in Utah and effectiveness claims
...Utahns without human clinical oversight. In the pilot first phase, the renewals, which include 192 drugs for chronic conditions, will be overseen by clinicians before being sent to a pharmacy, but the intent is to move through this phase quickly to a pilot of full prescription renewal autonomy. Utah is permitting this through the Utah Department of Commerce’s Office of Artificial Intelligence Policy. The goal is to speed renewals of maintenance medications, the majority of activity, thus reducing medication noncompliance. Non-compliance is a leading driver of preventable health outcomes and with health decline, avoidable spending. Utah Department of Commerce release,... Continue Reading
Perspectives: Telehealth as Infrastructure–Building a Financially and Clinically Sustainable Virtual Channel
...elsewhere. Make governance non-negotiable Without clear operational ownership, telehealth programs drift and performance deteriorates. Who owns booking rules? Who maintains payer mappings? What are clear escalation policies for clinical red flags? Assign cross-functional ownership (e.g. operations, revenue cycle, clinical leaders, and IT) and lock in a change-control cadence that prevents “rule drift” as policies and payer contracts change. Evidence that EHR workload-per-visit can rise even when visit volume falls illustrates why governance and workflow redesign must accompany modality shifts. Pilot pragmatically—and scale what earns results Don’t rip-and-replace overnight. Start with two tightly scoped pilots: for example, telehealth follow-ups for chronic... Continue Reading
Some more Ladders, tall and short: telepsych Grow Therapy’s $150M Series D, UnityAI’s $8.5M Series A; Health Recovery Solutions buys Rimidi
...release, Mobihealthnews And in local (to this Editor) news, Health Recovery Solutions buys Rimidi. Not the Italian Adriatic resort, Rimidi is an Atlanta-based software and services provider for chronic disease management and remote patient monitoring for diabetes and cardiometabolic conditions. Physician founded, it targeted to health systems, physician practices, value-based care organizations, and community health centers such as FQHCs and RHCs. No acquisition cost nor staff transition were disclosed. Dr. Lucienne Ide, MD, PhD Rimidi’s CEO and founder, joins HRS as chief medical officer. Health Recovery Solutions (HRS) provides remote patient monitoring (RPM), chronic care management (CCM), and longitudinal virtual... Continue Reading
Chutes & Ladders: UnitedHealth’s sideways ’26, longtime exec Cianfrocco departs; CHAI’s concept failure and future; KeyCare’s $27M Series A
...the leading EHR system, Epic, acting as an integrated virtual primary care extension partner for health systems. It is not only a 24/7 virtual care model with clinicians that provide urgent, preventive, chronic, and primary care, but also connects that care back to the patient’s home health system. The Chicago-based company states that it will invest further in AI-enabled technology, expand operational capacity to meet growing demand from health system partners, and continue scaling its platform to improve patient experience and provider efficiency, This round was led by HealthX Ventures with participation from previous investors 8VC, LRVHealth, BOLD Capital Partners,... Continue Reading
Rock Health’s sunnier 2025: up 35% due to AI, but a tale of ‘have and have nots’
...now at a post-F financing. There is zero here about bankruptcies and reorganizations. No reference to the utter implosion of 23andMe and its shocking sale back to founder/CEO Anne Wojcicki. The impact of ACCESS and ELEVATE. There is also a good graphic analysis of two CMS models that may support digital health more comprehensively than previous value-based care models such as ACO shared savings. The first CMMI model, ACCESS, will be debuting in July and is a 10 year voluntary payment model for Original Medicare outcomes in chronic care management. It reduces barriers for digital health to profitably work with... Continue Reading
Most Recent Comments